Somi Igbene, PhD, science writer —

Unhealthy changes in cognition, like a focus on worries, can lead to anxiety in people with pulmonary hypertension(PH), while those in behavior, like social avoidance, may cause depression, according to a U.K. study. Greater dyspnea, or shortness of breath, was also a contributing factor when paired with these cognitive or…

The National Institutes of Health (NIH) has granted Aqualung Therapeutics two three-year awards totaling $4.8 million to develop ALT-100, a humanized monoclonal antibody, for the treatment of pulmonary arterial hypertension (PAH) and inflammatory bowel disease (IBD). ALT-100 is designed to address and prevent inflammation in severe inflammatory…

Despite recent advances in care, mortality while in the intensive care unit (ICU) and up to one year thereafter remains high among people with pulmonary arterial hypertension (PAH), a new study reports. Risk factors for mortality one year after ICU discharge included low blood sodium, raised pro-B-type natriuretic peptide…

Nearly a third of individuals with chronic thromboembolic pulmonary hypertension (CTEPH) live with mental health disorders that impair their overall quality of life, a study in Germany has found. The significant impact of panic disorder, major depression, and other mental disorders on life quality suggests that adequate screening tools…

Team PHenomenal is inviting individuals with pulmonary hypertension to apply for $500 grants starting March 1 to help cover living expenses for those whose incomes have been affected by the COVID-19 pandemic. The Unmet Needs Patient Impact Fund can be used to pay for utility bills, home repairs,…